Erik Greb

Registry data suggest that among clots rich in red blood cells, those with low platelet content are associated with less disability and lower mortality after mechanical thrombectomy.

The approval was based on a phase 3 trial showing daridorexant was associated with improved sleep onset, sleep maintenance, and daytime functioning in adults with insomnia.

Risk for subsequent stroke does not differ significantly for outpatient care of transient ischemic attack or minor stroke vs inpatient care, a new meta-analysis suggests.

Although dopamine agonists and dopamine reuptake inhibitors (DRIs) may be effective in treating Parkinson’s disease and motor fluctuations not controlled with levodopa, not all DRIs are equal.

The association between air pollution and white matter hyperintensity volume is stronger among individuals who engage in vigorous physical activity for 30 or more minutes per week, new research shows.

Diabetes is associated with a higher risk for incident Parkinson’s disease and with worse motor symptoms, more rapid disease progression, new research suggests.

Use of allopurinol, a xanthine oxidase inhibitor, did not reduce progression of white matter hyperintensity (WMH) after stroke in a randomized trial.

Rasagiline 1 mg/d does not affect free-water accumulation in the posterior substantia nigra, a marker of disease progression, a new randomized trial suggests.

Cognitive reserve does not protect cognition for patients with vascular brain injury, new research shows.

Methylphenidate is associated with a significantly greater reduction in apathy in patients with Alzheimer’s disease compared with placebo -- and has a good safety profile, a new phase 3 trial suggests.

The US Food and Drug Administration has approved atogepant, a novel calcitonin gene-related peptide receptor antagonist for the prevention of migraine.

Short sleep duration is associated with impaired memory whereas long sleep is associated with impaired executive function, new research suggests. However, only one is linked to increased amyloid burden.

Overall number of global deaths by suicide rose by nearly 20,000 between 1990 and 2019, despite decreases in age-specific suicide rates, new research shows.

MRI measures have a weak and variable link to disability in patients with secondary progressive multiple sclerosis, new research suggests. However, newer measures may better reflect outcomes.

Dipyridamole shows promise for restless legs syndrome, reducing symptoms and improving sleep. It potentially offers new treatment option, early research suggests.

Intensive blood-pressure reduction as treatment for intracranial hemorrhage is linked to a significant risk for death or disability in patients with impaired kidney function.

Highly respected and beloved pediatric neurologist Verne Strudwick Caviness, Jr, attended on the stroke and child neurology services at Massachusetts General Hospital in Boston for five decades.

Stroke survivors with a walking speed of at least 0.8 m/sec can improve their ability to simultaneously walk and perform a second task following training, new research suggests.

An investigational oral treatment is more effective than placebo in providing pain freedom and freedom from the most bothersome symptom at 2 hours, new phase 3 results suggest.

During a migraine attack, the IV monoclonal antibody eptinezumab provides freedom from pain in as little as 1 hour after administration, new research suggests.